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The effects of Epley’s maneuver in benign paroxysmal 
positional vertigo (BPPV) associated with Menière’s disease 
are controversial. Aims: To evaluate the progression of 
positional vertigo and nystagmus after one or more of Epley’s 
maneuvers in BPPV associated with Menière’s disease, and 
the recurrence of BPPV. Method: a retrospective study of 62 
patients with BPPV associated with Menière’s disease, that 
underwent Epley’s maneuver, and that were monitored during 
12 months after elimination of positional nystagmus. Results: 
One Epley’s maneuver was required to eliminate positional 
nystagmus in 80.7% of the patients, two in 16.1%, and three 
in 3.2%; after elimination of nystagmus, positional vertigo 
was suppressed in 71.0% of the patients, improved in 27.4% 
and remained unaltered in 1.6%. Four weeks after elimination 
of positional nystagmus, all patients were asymptomatic. 
Recurrence of BPPV was seen in 19.4% of the cases, with 
elimination of the positional vertigo and nystagmus by 
means of the specific maneuver for the involved canal. 
Conclusions: In BPPV associated with Menière’s disease, 
vertigo and positioning nystagmus were eliminated with one, 
two or three Epley maneuvers. BPPV recurrence was resolved 
by using a specific maneuver for the affected canal.
Keywords: labyrinth, meniere’s disease, positional nystagmus, 
dizziness.
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INTRODUCTION
In 1861, Prosper Ménière described a symptom triad 
composed of paroxystic events of tinnitus, hearing loss 
and vertigo with no central nervous system involvement. 
This condition received the name Ménière’s disease, being 
currently defined as an idiopathic endolymphatic hydrops 
syndrome.
According to the Committee on Hearing and Equi-
librium guidelines for the diagnosis and evaluation of 
therapy in Ménière’s disease of the American Academy 
of Otolaryngology - Head and Neck Foundation, Inc.,1 
Ménière’s disease is characterized by periodic crises. 
These are spontaneous and recurring vertigo events that 
vary from patient to patient and depend on the stage of 
the disease, lasting at least 20 minutes, and that usually 
are accompanied by nausea and/or vomiting; there is also 
spontaneous nystagmus (always present during a crisis), 
hearing loss, fullness of the ear and tinnitus in the affected 
side, and no loss of conscience.
Adler (in 1897) and Báràny (in 1921) described 
vertigo and paroxysmal nystagmus due to changes in the 
position of the head. Dix and Hallpike created a test to 
assess vertigo and positional nystagmus, and proposed the 
name benign paroxysmal positional vertigo (BPPV) for the 
condition that included the abovementioned signs.2
Dizziness upon head movements in BPPV would 
result from the undue presence of calcium carbonate par-
ticles resulting from fragmentation of canaliths from the 
macula acustica utriculi. Schuknecht3 and Schuknecht, and 
Ruby4 defined cupulolithiasis as the situation where these 
particles become deposited in the cupula of the posterior 
semicircular canal. Hall et al.5 proposed that these parti-
cles would float freely in the posterior semicircular canal 
(canalithiasis) rather than being fixed to the cupula. In 
1983, Paparella and Mancini6 suggested that floating par-
ticles could cause labyrinthic hydrops due to obstruction 
of endolymphatic flow. In 1984, Paparella7 suggested that 
endolymphatic hydrops would cause positional vertigo 
in Ménière’s disease due to saccular distension up to the 
semicircular canals.
BPPV may be associated with Ménière’s disease or 
occur at any stage of this disease, usually during its stability 
phase, months or years after vertigo has regressed.8-18 On 
the other hand, Ménière’s disease may be considered as 
one of the causes of persisting vertigo in posterior semi-
circular canal BPPV patients.19
Epley20 described a canalith repositioning maneuver. 
A series of head movements would replace canalith frag-
ments back in the utricle, where they would be absorbed 
or eliminated by the endolymphatic sac. This maneuver 
results in high improvement or cure rates and is frequently 
used in the treatment of BPPV that involves the anterior 
or posterior semicircular canals.21 If positional nystagmus 
persists, the maneuver should be repeated weekly until 
this ocular movement is abolished.
The maneuver has undergone various modifications 
throughout the years, all with similar success rates.22-25
Recurrence is common and require repetition of the 
maneuver.20,26-35 BPPV-associated endolymphatic hydrops 
may lead to recurring vertigo and positional nystagmus 
after repositioning maneuvers, with persistence of symp-
toms in some patients.12,36-38
The aim of this paper was to assess the clinical pro-
gression of vertigo and positional nystagmus after one or 
more Epley’s maneuvers in BPPV patients with Ménière’s 
disease and upon recurrence of BPPV.
METHOD
This study was approved by the Research Ethics 
Committee of the institution in which the trial was done 
(protocol number 04821/04).
The sample series was selected from 1,946 new con-
secutive patient charts diagnosed as having BPPV and/or 
Ménière’s disease by an otorhinolaryngologist between 
January 1999 and July 2004. Inclusion criteria were patients 
diagnosed with BPPV and positional nystagmus evoked 
by the Dix-Hallpike test, a final diagnosis of Ménière’s 
disease in which Epley’s maneuver was used as the only 
treatment for BPPV and that were followed-up during 
twelve months after the Epley maneuver that abolished 
positional nystagmus.
The diagnosis of Ménière’s disease was based on 
criteria established by the Committee on Hearing and 
Equilibrium guidelines for the diagnosis and evaluation of 
therapy in Ménière’s disease of the American Academy of 
Otolaryngology-Head and Neck Foundation, Inc.1 Patients 
with uncontrolled Ménière’s disease used vestibular sup-
pressant and antiemetics drugs during crises of vertigo.
The diagnosis of BPPV was based on reports of 
rotary dizziness upon changes in the position of the head, 
when moving to one or the other side while supine, when 
moving to the erect position or when looking upwards. 
Nausea and vomiting may be present or not, and vertigo 
and positional nystagmus are evoked by the Dix-Hallpike 
test. Between crises, there may be intermittent instability 
or other types of variable degree dizziness.15
The Dix-Hallpike test (lateral decubitus) was used to 
investigate positional nystagmus. The characteristics of po-
sitional nystagmus, when present, indicated the labyrinth 
and the semicircular canal that were involved and permit-
ted the distinction between canalithiasis (nystagmus lasting 
less than a minute) and cupulolithiasis (nystagmus lasting 
more than one minute). Vertigo and/or nausea, latency, 
paroxysm and fatigue upon repetition of the procedure 
were signaled. Vertical upbeat and rotary positional nys-
tagmus characterized posterior canal involvement; vertical 
downbeat and rotary positional nystagmus characterized 
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anterior canal involvement; rotary clockwise or counterclo-
ckwise positional nystagmus indicated involvement of the 
vertical canal without separating the anterior and posterior 
canals, and geotropic or ageotropic horizontal positional 
nystagmus indicated lateral canal involvement.15
Sixty-two BPPV patients and a final diagnosis of 
Ménière’s disease fulfilled the inclusion criteria for this trial. 
Thirty-nine (62.9%) patients were female and 23 patients 
(37.1%) were male. Age ranged from 23 to 86 years (mean 
- 54.2 years). All subjects were Caucasian.
BPPV associated with Ménière’s disease patients 
underwent pure tone audiometry, voice audiometry, 
immitance testing and electrocochleography. Vestibular 
function was assessed by computerized nystagmography 
(Micromedical Technologies Inc., USA), which involved 
the following tests: calibration of ocular movements, inves-
tigation of positional/positioning nystagmus, spontaneous 
and semi-spontaneous nystagmus, fixed and randomized 
saccadic movements, pendular tracking, optokinetic nys-
tagmus, self-rotation of the head and the air caloric test. 
A Dix-Hallpike test was done using video-Frenzel lenses 
(Neurograff Eletromedicina Ind. e Com. Ltda - EPT - Brazil) 
to define the involved canal and labyrinth.
The Epley maneuver was done in every case to 
reposition canalith particles from the semicircular canal 
back into the utricle. Patients were not prescribed restric-
ted postures after the maneuver. Patients were evaluated 
by Dix-Hallpike testing one week later. If positional nys-
tagmus persisted, Epley’s maneuver was repeated. This 
was done weekly, if needed, until positional nystagmus 
subsided. Patients were again evaluated by Dix-Hallpike 
testing four weeks after positional nystagmus had been 
abolished.39
Patients were informed about the possibility of 
recurrence of BPPV signs and symptoms, which would 
require them to return for reassessment and retreatment. 
Upon recurrence of vertigo and positional nystagmus on 
Dix-Hallpike testing, Epley’s maneuver was repeated in 
cases with vertical semicircular canal involvement; cases 
where the lateral semicircular canal was involved were 
treated with Lempert’s and Tiel-Wilck’s40 positional ma-
neuver.
Findings were analyzed statistically, starting with 
the descriptive analysis of data. The chi-square test was 
used in analyzing the association between frequencies of a 
two-category sample, followed by Yates’s correction. The 
chi-square test was also used in checking the association 
of frequencies in a three-category sample. The chi-square 
(x2) test was used in evaluating the association between 
two independent samples in a contingency table. Fisher’s 
exact test was used in identifying the association between 
variables in the contingency table in which 25% of cells 
had occurrences below five. The Kaplan-Meier test was 
used in analyzing BPPV recurrence prediction where a 
group of subjects was assessed in given periods (days or 
months) at unequally spaced intervals. The significance 
level for statistical tests was 5% (α = 0.05).
RESULTS
Charts from 1,946 new consecutive patients with a 
diagnostic hypothesis of BPPV and/or Ménière’s disease 
between January 1999 and July 2004 were analyzed. BPPV 
was diagnosed in 1033 cases (53.1%), Ménière’s disease 
was diagnosed in 841 cases (43.2%) and BPPV associated 
with Ménière’s disease was diagnosed in 72 cases (3.7%). 
Ten BPPV associated with Ménière’s disease patients were 
excluded due to loss of follow-up.
Sixty-two patients with BPPV and a final diagnosis 
of Ménière’s disease fulfilled the inclusion criteria for this 
study. BPPV started before Ménière’s disease in one patient 
(1.6%); the onset of BPPV coincided with that of Ménière’s 
disease in four patients (6.5%); the onset of BPPV was after 
stabilization of the clinical picture of Ménière’s disease 57 
patients (91.9%).
On the Dix-Hallpike test, all 62 patients showed 
vertigo and positional nystagmus with latency, paroxism, 
duration below one minute and fatigue upon repeating 
the procedure. Positional nystagmus suggested unilateral 
involvement of the posterior semicircular canal in 62 
patients, as follows: vertical upbeat rotatory counterclo-
ckwise positional nystagmus in the right lateral decubitus 
characterizing right labyrinth involvement in 37 cases 
(59.7%), and  vertical upbeat rotatory clockwise positional 
nystagmus in the left lateral decubitus characterizing left 
labyrinth involvement in 25 cases (40.3%).
Ménière’s disease was unilateral in 40 cases (64.5%) 
and bilateral in 22 cases (35.5%). In unilateral cases, ri-
ght labyrinth involvement occurred in 20 patients (50%) 
and left labyrinth involvement was found in 20 patients 
(50%).
Table 1 shows the number of cases of BPPV associa-
ted with Ménière’s disease according to the labyrinth that 
was involved. In right labyrinth BPPV Ménière’s disease 
was ipsilateral in 20 patients (54.1%), contralateral in one 
patient (2.7%) and bilateral in 16 patients (43.2%). In left 
labyrinth BPPV, Ménière’s disease was ipsilateral in 19 
patients (76%) and bilateral in six patients (24%). There 
was a significant association between involvement of both 
labyrinths in the two diseases (p<0.001). BPPV tended to 
be prevalent in the right labyrinth in patients with bilateral 
involvement of Ménière’s disease (p=0.055).
Table 2 shows that one session of Epley’s maneuver 
was needed to eliminate positional nystagmus in BPPV in 
50 patients (80.7%), two sessions of Epley’s maneuver was 
needed in 10 patients (16.1%) and three sessions of Epley’s 
maneuver was needed in two patients (3.2%). The need 
for one session of Epley’s maneuver to abolish positional 
nystagmus was much more frequent than the need for two 
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or three sessions of Epley’s maneuver (p<0.001).
The progression of positional vertigo on the 
Dix-Hallpike test is shown on Table 3. After positional 
nystagmus was abolished by Epley’s maneuver, 44 cases 
(71%) remained asymptomatic, 17 cases (27.4%) reported 
improvement and one case (1.6%) was unaltered. Asymp-
tomatic cases were significantly more prevalent compared 
to improved and unaltered cases (p<0.001).
Four week after the extinction of positional nystag-
mus, all 62 patients were asymptomatic and showed no 
positional vertigo on the Dix-Hallpike test.
BPPV relapsed in 12 cases (19.4%) as seen on 
follow-up 12 months after the maneuver that abolished 
positional nystagmus; these patients presented vertigo and 
positional nystagmus on the Dix-Hallpike test. Absence of 
recurrence of BPPV was significantly more frequent than 
the occurrence of relapses (p<0.001).
BPPV relapsed in two patients (3.2%) at two mon-
ths, in one patient (1.6%) at three months, in two patients 
(3.2%) at six months, in two patients (3.2%) at eight mon-
ths, in one patient (1.6%) at nine months, in one patient 
(1.6%) at 10 months, in two patients (3.2%) at 11 months 
and in one patient (1.6%) at 12 months after the maneuver 
that abolished positional nystagmus.
BPPV recurrence was observed in the same la-
byrinth as before in ten cases (83.3%) and in the opposite 
labyrinth in two cases (16.7%). The posterior semicircular 
canal was involved in eight patients, the anterior semi-
circular canal was involved in one patient and the lateral 
semicircular canal was involved in three patients. Recurring 
vertigo and positional nystagmus were abolished after one 
session of Epley’s maneuver in cases where the anterior 
or posterior semicircular canals were involved, and after 
Lempert’s and Tiel-Wilck’s positional maneuver in cases 
where the lateral semicircular canal was involved.
Table 1. Number of cases of benign paroxysmal positional vertigo 
associated with Ménière’s disease, according to the labyrinth that 
was involved
Ménière’s disease
Condi-
tion
Right 
labyrinth
Left la-
byrinth
Bilateral Total
BPPV
Right 
labyrinth
20 1 16 37
Left la-
byrinth
0 19 6 25
Total 20 20 22 62
Key:BPPV - benign paroxysmal positional vertigo
Test - Fisher’s exact test
Significance - p<0.001
Table 2. Number and percentage of patients with benign paroxys-
mal positional vertigo associated with Ménière’s disease according 
to the number of sessions of Epley’s maneuver needed to abolish 
positional nystagmus.
Number of Epley’s 
maneuvers
Patients with BPPV and Ménière’s disease
Number %
One 50 80,7
Two 10 16,1
Three 2 3,2
Total 62 100,0
Key:BPPV - benign paroxysmal positional vertigo
Test - chi-square
Significance - p<0.001
Table 3. Number and percentage of patients with benign paroxys-
mal positional vertigo associated with Ménière’s disease according 
to the progression of positional vertigo in the Dix-Hallpike test one 
week following Epley’s maneuver that resulted in extinction of posi-
tional nystagmus.
Progression of posi-
tional vertigo in the 
Dix-Hallpike test
Patients with BPPV and Ménière’s disease
Number %
Asymptomatic 44 71,0
Improved 17 27,4
Unaltered 1 1,6
Total 62 100,0
Key:BPPV - benign paroxysmal positional vertigo
Test - chi-square
Significance - p<0.001
Figure 1. Kaplan-Meier estimator for the curve of non-recurring cases 
of benign paroxysmal positional vertigo up to 12 months in 62 patients 
with Ménière’s disease.
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Figure 1 shows the Kaplan-Meier estimator for the 
curve of non-recurring cases. The accumulated BPPV 
recurrence chance was 3.3% at two months, 5% at three 
months, 8.3% at six months, 11.6% at eight months, 13.3% 
at nine months, 14.9% at 10 months, 18.3% at 11 months 
and 19.9% at 12 months.
DISCUSSION
BPPV is a clinical entity with a high incidence in 
the world population; it may be considered as the most 
frequent vestibular condition.15,41-42 This disease is benign 
and may be treated by specific vestibular rehabilitation 
procedures, such as canalith repositioning procedures, 
vestibular suppressant drugs or surgery in refractory cases 
to medical treatments.15,37,42
In the initial survey for this study, 1,105 patients 
were diagnosed as having BPPV, of which 1,033 cases 
(53.1% of the total number of charts that were evaluated) 
had BPPV exclusively and 72 cases (6.5%) had BPPV as-
sociated with Ménière’s disease. Seventy-two (7.9%) of 913 
patients (46.9% of the total number of charts that were eva-
luated) diagnosed as having Ménière’s disease had BPPV. 
Ten BPPV patients associated with Ménière’s disease were 
excluded from our series due to loss of follow-up. BPPV 
may be associated with Ménière’s disease or with other 
otoneurological diseases.9-13,38 The occurrence of Ménière’s 
disease in BPPV patients has been cited in other papers 
as representing 0.6%,13 0.9%,8 2.1%,9 3.2%16 and 29.8%10 of 
cases. BPPV in patients with Ménière’s disease has been 
diagnosed by various authors in 5.5%,36 10.0%,37 11.5%,12 
14.1%38 and 44.0%11 of cases.
In this study 39 patients (62.9%) with BPPV asso-
ciated with Ménière’s disease were females aged between 
23 and 86 years (mean age was 54.2 years), similar to 
findings in papers on BPPV associated with Ménière’s 
disease.10,36-38.
In our series, the onset of BPPV occurred after sta-
bilization of Ménière’s disease in 57 cases (91.9%). This 
finding is comparable to that in a study in which the onset 
of BPPV occurered after Ménière’s disease in all cases.36 
Some authors have reported that the onset of BPPV oc-
curred after Ménière’s disease in 33.3% of cases, and that 
it was not possible to establish the initial entity in 64.5% 
of cases.10 According to other authors, the onset of both 
diseases was simultaneous in 55.6% of cases.37
Involvement of the posterior semicircular canal by 
canalithiasis occurred in all the 62 patients with Ménière’s 
disease and BPPV that were evaluated in this study, which 
is similar to findings by other authors.9,37-38 Localization 
in the posterior semicircular canal appears to favor the 
migration of canaliths that become detached from the 
utricle.31
BPPV was unilateral in all of the cases of this stu-
dy, occurring in the same labyrinth that was affected by 
unilateral Ménière’s disease in 39 patients (62.9%) and 
contralateral to unilateral Ménière’s disease in only one 
case (1.6%). These findings agree with published data in 
the literature where most cases of BPPV were unilateral 
and the affected side was the same as that involved by 
Ménière’s disease.10,36-38 There was no mention in the 
literature we consulted about the occurrence of BPPV in 
the ear not affected by Ménière’s disease. In our cases of 
bilateral Ménière’s disease, BPPV tended to present in the 
right labyrinth.
Ménière’s disease is a possible etiology for BPPV.7,12-
13 This study demonstrated that most of the cases of 
unilateral BPPV occurred after the onset of ipsilateral 
Ménière’s disease, reinforcing the idea that the latter con-
dition might alter the otolytic organ and be responsible for 
loosening particles that then migrate to the semicircular 
canals, resulting in canalithiasis. Floating canaliths might 
induce endolymphatic hydrops by obstructing longitudi-
nal endolymphatic flow.7 In cases where BPPV preceded 
Ménière’s disease, floating canalith fragments might induce 
hydrops by mechanically obstructing endolymphatic flow 
and by altering the absorption of endolymph.6
A single session of Epley’s maneuver was sufficient 
to eliminate positional nystagmus on the Dix-Hallpike test 
in 80.7% of patients diagnosed as having BPPV associa-
ted with Ménière’s disease. This finding is significantly 
higher than the need for using two or three sessions of 
Epley’s maneuver for similar results. One week after per-
forming one to three sessions of Epley’s maneuver 98.4% 
of cases became asymptomatic or improved substantially 
from positional vertigo. Asymptomatic cases were more 
frequent than improved or unaltered cases. Four weeks 
after abolishing positional nystagmus, all 62 patients were 
asymptomatic and presented no positional vertigo on the 
Dix-Hallpike test. Notwithstanding the extinction of po-
sitional nystagmus on the Dix-Hallpike test, persistence 
of positional vertigo in BPPV after the repositioning pro-
cedure may be due to remaining canalith particles in the 
posterior canal. These particles would be insufficient to 
flex the cupula and produce nystagmus, but would suffice 
to induce vertigo.17
The efficacy of Epley’s maneuver in the treatment 
of BPPV patients has been underlined in the literature.16-
17,20-21,26,28,30-35,42,43-45 Only a few authors with smaller series 
compared to this series have investigated Epley’s maneu-
ver in patients diagnosed as having BPPV associated with 
Ménière’s disease. Two patients remained with positional 
vertigo and four patients remained with nystagmus as 
evidenced by the Dix-Hallpike test.46 Elimination of posi-
tional nystagmus with the persistence of dizziness or mild 
positional unbalance was seen in 32.1% of the affected 
labyrinths.12 Repeated repositioning procedures resulted 
in temporary improvements in one patient, elimination of 
symptoms in another patient and persistence of vertigo e 
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do nystagmus.37
Some authors12,36-37 have reported increased difficul-
ties in resolving BPPV associated with Ménière’s disease 
compared to our findings for cases in which the onset of 
BPPV occurred after that of Ménière’s disease. Improve-
ment of vertigo and elimination of positional nystagmus, 
however, was seen in 83.3% of cases of BPPV associa-
ted with Ménière’s disease after a single repositioning 
procedure,38 which may be considered as similar to our 
findings in this study.
The success of treating BPPV secondary to some 
other labyrinthic disease by Epley’s maneuver, including 
Ménière’s disease cases, is usually inferior compared to 
cases of idiopathic BPPV.16
After successful treatment of BPPV patients by 
using Epley’s maneuver, recurrence rates of signs and 
symptoms have been quoted at 6.6%32 to 12.0% of cases 
after six months,31 15%27 to 30%20,26 of cases at one year, 
50% of cases at 40 months,28 37% of cases 60 months after 
treatment,29 and 43% of cases at two years.33 Recurrence 
was seen in 50% of cases after a ten-year follow-up period. 
Recurrences occurred in 80% of cases during the first year 
following the treatment.35
The one-year follow-up of our patients diagnosed 
as having BPPV associated with Ménière’s disease showed 
recurrence of vertigo and positional nystagmus in 19.4% of 
cases two to 12 months after the repositioning maneuver 
that abolished positional nystagmus. The number of cases 
with no recurrence of BPPV was significantly higher than 
the number of recurring cases. Studies on patients diag-
nosed as having Ménière’s disease associated with BPPV 
have shown a 50% recurrence rate12,38 between on average 
8.3 months to one year.
The recurrence of BPPV in this study was in the 
same side and the same semicircular canal that had been 
involved previously. Only two cases recurred in the op-
posite side, as has been reported in the literature.36-38 Re-
currence in a semicircular canal other than the previously 
involved canal was seen in four cases, of which three 
were in the lateral canal and one in the anterior canal. 
We found no references of BPPV recurrence in a different 
semicircular canal in patients with Ménière’s disease. We 
also found no explanation for recurrence in the opposite 
side in patients diagnosed as having BPPV with Ménière’s 
disease. Ménière’s disease might be responsible for BPPV 
recurrence in the opposite labyrinth.
Treatment with a single repositioning procedure was 
successful in all of the recurring BPPV cases in this study. 
Patients reported partial improvement from BPPV after 
repositioning procedures, with persistence of positional 
vertigo that was tolerable in routine activities. Some authors 
have noted that Ménière’s disease might predispose the 
patient to intractable BPPV, as all of their patients had on 
average two to three BPPV recurrences within one year, 
possibly due to permanent structural damage to the macula 
or the membranous labyrinth.36
In our study, we found that within one year follo-
wing the session of Epley’s maneuver that abolished 
positional nystagmus, the accumulated chance of BPPV 
recurrence varied from 3.3% after two months to 19.9% 
after 12 months. No information was found in the literature 
for comparison with this finding.
Findings in this study demonstrated that Epley’s 
maneuver was effective in the treatment of BPPV and its 
relapses in patients with Ménière’s disease. It is essential 
to inform patients with a diagnosis of Ménière’s disease 
associated with BPPV about possible recurrences of po-
sitional vertigo and the need for further treatment. These 
patients should be under long-term monitoring.
CONCLUSION
After one, two  or three sessions of Epley’s maneu-
ver in BPPV patients associated with Ménière’s disease, 
the findings were as follows: 
1) elimination of positional nystagmus; 
2) elimination of positioning vertigo in up to four 
weeks after extinction of positional nystagmus, and 
3) follow-up at 12 months showed BPPV recur-
rence cases in which vertigo and positional nystagmus 
were abolished after one maneuver aimed at the diseased 
semicircular canal.
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